Zenas BioPharma, Inc. (ZBIO)
29.43
+1.17
(+4.14%)
USD |
NASDAQ |
Nov 09, 14:29
Zenas BioPharma Market Cap : 1.864B for Nov. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 06, 2026 | 1.790B |
| November 05, 2026 | 1.642B |
| November 04, 2026 | 1.802B |
| November 03, 2026 | 1.797B |
| November 02, 2026 | 1.749B |
| October 30, 2026 | 1.798B |
| October 29, 2026 | 1.821B |
| October 28, 2026 | 1.822B |
| October 27, 2026 | 1.729B |
| October 26, 2026 | 1.725B |
| October 23, 2026 | 1.702B |
| October 22, 2026 | 1.788B |
| October 21, 2026 | 1.778B |
| October 20, 2026 | 1.785B |
| October 19, 2026 | 1.692B |
| October 16, 2026 | 1.573B |
| October 15, 2026 | 1.609B |
| October 14, 2026 | 1.574B |
| October 13, 2026 | 1.593B |
| October 12, 2026 | 1.672B |
| October 09, 2026 | 1.726B |
| October 08, 2026 | 1.662B |
| October 07, 2026 | 1.785B |
| October 06, 2026 | 1.706B |
| October 05, 2026 | 1.762B |
| Date | Value |
|---|---|
| October 02, 2026 | 1.792B |
| October 01, 2026 | 1.769B |
| September 30, 2026 | 1.708B |
| September 29, 2026 | 1.695B |
| September 28, 2026 | 1.745B |
| September 25, 2026 | 1.707B |
| September 24, 2026 | 1.742B |
| September 23, 2026 | 1.876B |
| September 22, 2026 | 2.093B |
| September 21, 2026 | 2.061B |
| September 18, 2026 | 1.995B |
| September 17, 2026 | 2.025B |
| September 16, 2026 | 2.047B |
| September 15, 2026 | 2.022B |
| September 14, 2026 | 2.021B |
| September 11, 2026 | 1.971B |
| September 10, 2026 | 1.970B |
| September 09, 2026 | 2.045B |
| September 08, 2026 | 2.093B |
| September 04, 2026 | 2.082B |
| September 03, 2026 | 2.085B |
| September 02, 2026 | 2.098B |
| September 01, 2026 | 2.025B |
| August 31, 2026 | 2.047B |
| August 28, 2026 | 1.980B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.367B |
| Alnylam Pharmaceuticals, Inc. | 20.98B |
| Anika Therapeutics, Inc. | 195.12M |
| Savara, Inc. | 1.023B |
| Vericel Corp. | 2.980B |
Market Cap Related Metrics
| PS Ratio | 154.76 |
| PEG Ratio | -0.0241 |
| Price to Book Value | 9.398 |
| Price | 29.43 |
| Earnings Yield | -34.12% |
| PEGY Ratio | -0.0241 |